Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03943212 · ClinicalTrials.gov registry record · NA
The Effect of Blood Flow Rate on Dialysis Recovery Time in Patients Undergoing Maintenance Hemodialysis
A NA study, sponsored by Satellite Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT03943212 is a NA study that has completed, run by Satellite Healthcare. The registered enrollment target is 102 participants.
The verdict
NCT03943212, a NA study, has completed, sponsored by Satellite Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
A majority of patients with end-stage renal disease (ESRD) on in-center hemodialysis (HD) require several hours to recover from fatigue after an HD session. Evidence for practical interventions to improve this recovery time from conventional in-center HD is lacking. This study investigates the effects of reducing HD blood flow rates on patients' self-reported post-dialysis fatigue.
Interventions
- OTHER Control
- OTHER Blood Flow Rate Reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2017-09-26 |
| Est. Completion | 2018-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03943212
The ClinicalTrials.gov registry entry for NCT03943212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Satellite Healthcare, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03943212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03943212 about?
NCT03943212 is a clinical study titled "The Effect of Blood Flow Rate on Dialysis Recovery Time in Patients Undergoing Maintenance Hemodialysis". A majority of patients with end-stage renal disease (ESRD) on in-center hemodialysis (HD) require several hours to recover from fatigue after an HD session. Evidence for practical interventions to improve this recovery time from conventional in-center HD is lacking. This study investigates the effec...
What is the current status of trial NCT03943212?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2017-09-26. Estimated completion is 2018-05-24.
What interventions are being tested in trial NCT03943212?
The interventions under investigation include: Control (OTHER), Blood Flow Rate Reduction (OTHER).
Who is sponsoring clinical trial NCT03943212?
This trial is sponsored by Satellite Healthcare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.